This High-Yield Dividend Portfolio Will Beat the Market
Published Tue, 12 Apr 2011 on The Motley Fool

Movers & ShakersOf our stocks, again, the biggest mover in the portfolio the past two weeks was Bristol-Myers Squibb, which rose 7.5%. The stock first jumped two Fridays ago when, as Fool Pharma Analyst Brian Orelli expected, the FDA approved the firm’s melanoma drug Yervoy. The drug is a breakthrough in that it is the first time a drug has significantly extended survival for melanoma patients. Money!There are 2 upcoming dividends for the portfolio:... Read more